Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a minor behind-the-scenes update to the page without changing study information.
    Difference
    0.0%
    Check dated 2026-06-05T11:22:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a newer revision tag, Revision: v3.5.4, replacing Revision: v3.5.3. This signals a small backend or QC update to the page rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-05-15T02:21:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.2 to v3.5.3, indicating a software update to the page. It updates the version identifier displayed to users.
    Difference
    0.0%
    Check dated 2026-04-30T16:50:47.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:35:23.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:28:24.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T12:40:07.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.